Acurian Delivers 895 Patients and Saves an Average of Two Months for a Five-protocol Hypertension Clinical Trial

Cardiovasular

Hypertension

A sponsor began a multi-protocol, one-year phase III study to evaluate the safety and tolerability of its drug in subjects with essential hypertension.

Read More »